Evidence map›Paper›PMID 20504932›Full record

ArticleJournal of virology2010

Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.

Ileana M Cristea, Nathaniel J Moorman, Scott S Terhune, Christian D Cuevas, Erin S O'Keefe, Michael P Rout, Brian T Chait, Thomas Shenk

Abstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 156 citations in OpenAlex.

  1. Review
  2. Article
  3. RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ileana M CristeaDepartment of Molecular Biology, Princeton University, Princeton, New Jersey 08544-1014, USA.
Nathaniel J Moorman
Scott S Terhune
Christian D Cuevas
Erin S O'Keefe
Michael P Rout
Brian T Chait
Thomas Shenk
Princeton University · USRockefeller University · USMedical College of Wisconsin · US

Funding

NEW TOOLS FOR EXPLORING THE DYNAMIC INTERACTOME(RMI)U54RR022220 · NCRR · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2005 to 2011
$19.3M
YNG1 PHD BINDING TO H3 3METHYL AT K4 PROMOTES TRANSCRIPTION AT TARGETED ORFSP41RR000862 · NCRR · ROCKEFELLER UNIVERSITY · PI DARNELL, JAMES E · 1985 to 2011
$16.1M
HUMAN CYTOMEGALOVIRUS TEGUMENT PROTEINSR01CA082396 · NCI · PRINCETON UNIVERSITY · PI SHENK, THOMAS E · 1999 to 2013
$5.0M
Proteomic Tools to Uncover the Role of Chromatin Remodeling in HIV-1 InfectionDP1DA026192 · NIDA · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 2008 to 2012
$3.9M
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNASR01CA085786 · NCI · PRINCETON UNIVERSITY · PI SHENK, THOMAS E · 2000 to 2010
$3.7M
DISSECTING THE MOLECULAR MACHINERY OF NUCLEAR TRANSPORTR01GM062427 · NIGMS · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2001 to 2010
$2.7M
COMPREHENSIVE MAP OF CELLULAR PROTEIN INTERACTIONSR33CA089810 · NCI · ROCKEFELLER UNIVERSITY · PI CHAIT, BRIAN T · 2001 to 2003
$1.8M
NCI NIH HHS CA82396NCI NIH HHS CA85786NCI NIH HHS CA89810NCI NIH HHS R01 CA082396NCI NIH HHS R01 CA085786NCI NIH HHS R33 CA089810NCRR NIH HHS P41 RR000862NCRR NIH HHS RR00862NCRR NIH HHS RR22220NCRR NIH HHS U54 RR022220NIDA NIH HHS DP1 DA026192NIDA NIH HHS DP1DA026192NIGMS NIH HHS GM62427NIGMS NIH HHS R01 GM062427
6 · The paper itself

Abstract

The human cytomegalovirus (HCMV) virion protein pUL83 (also termed pp65) inhibits the expression of interferon-inducible cellular genes. In this work we demonstrate that pUL83 is also important for efficient induction of transcription from the viral major immediate-early promoter. Infection with a mutant virus containing a premature translation termination codon in the UL83 open reading frame (ORF) (UL83Stop) resulted in decreased transcription from the major immediate-early promoter in a time- and multiplicity-dependent manner. Expression of pUL83 alone is capable of transactivating the promoter in a reporter assay, and pUL83 associates with the promoter in infected cells. To investigate the mechanism by which the protein regulates the major immediate-early promoter, we utilized a mutant virus expressing an epitope-tagged pUL83 from its own promoter to identify protein binding partners for pUL83 during infection. We identified and confirmed the interaction of pUL83 with cellular IFI16 family members throughout the course of HCMV infection. pUL83 recruits IFI16 to the major immediate-early promoter, and IFI16 binding at the promoter is dependent upon the presence of pUL83. Consistent with the results obtained with the UL83Stop virus, infection of IFI16 knockdown cells with wild-type virus resulted in decreased levels of immediate-early transcripts compared to those of control cells. These data identify a previously unknown role for pUL83 in the initiation of the human cytomegalovirus gene expression cascade.

Indexed as

Genes, Immediate-EarlyHost-Pathogen InteractionsPromoter Regions, GeneticTranscriptional ActivationCells, CulturedCodon, NonsenseCytomegalovirusDNA, ViralFibroblastsGene Knockdown TechniquesGenes, ReporterHumansMutation, MissenseNuclear ProteinsPhosphoproteinsProtein BindingCodon, Nonsensecytomegalovirus matrix protein 65kDaDNA, ViralIFI16 protein, humanNuclear ProteinsPhosphoproteinsViral Matrix Proteins

Identifiers

PMID20504932
PMCPMC2897612
OpenAlexW2104912263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.